Back to search results

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC) · Cancer of Pancreas · Pancreatic Cancer, Adult · Pancreas Adenocarcinoma · Pancreatic Neoplasms · Pancreatic Cancer Non-resectable · Pancreatic Cancer Resectable

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Ashwin Somasundaram, MD) · ashwin@med.unc.edu · 919-966-5902
    Contact: Principal Investigator (Ashwin Somasundaram, MD)
    Contact: Principal Investigator (Jen Jen Yeh, MD)
    Hanna Sanoff, MD, PhD (Sub-investigator)
    Michael S. Lee, MD (Sub-investigator)
    Cheryl Carlson, MD, PhD (Sub-investigator)
    Tammy Triglianos, RN, NP (Sub-investigator)
    Ugwuji Maduekwe, MD (Sub-investigator)
    Hong Jin Kim, MD (Sub-investigator)
    Todd Baron, MD (Sub-investigator)
Study leads

  • Ashwin Somasundaram, MD

    Principal Investigator

    University of North Carolina, Chapel Hill

View source on ClinicalTrials.gov(opens in a new tab)